The data for 2023 indicates that the United Kingdom leads the European market for sold production of human blood and related products, with a significant share of 30.12%. Denmark follows with 25.08%, while Germany holds 14.6%, and Italy has 11.51%. France, with a slight negative trend, comprises 7.05% of the market. Notably, Spain experienced a significant 21.17% increase over the year. The Compound Annual Growth Rate (CAGR) over the last five years suggests steady growth, especially in smaller markets like Lithuania.
Future trends to watch include the potential impact of technological advancements in diagnostics and treatments, and regulatory changes. Continued growth is expected in emerging markets, fueled by increased demand for advanced medical products and therapies.
Top countries in Sold Production of Human Blood, Animal Blood Prepared for Therapeutic, Prophylactic or Diagnostic Uses, Cultures of Micro-Organisms, Toxins Share by Country (Euros)
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United Kingdom | 30.12 | 2023 | +2.32% | +1.49% | View data |
| 2 | 2 Denmark | 25.08 | 2023 | +2.89% | +2.4% | View data |
| 3 | 3 Germany | 14.6 | 2023 | +3.53% | +5.16% | View data |
| 4 | 4 Italy | 11.51 | 2023 | +5.31% | +1.75% | View data |
| 5 | 5 France | 7.05 | 2023 | -4.23% | -10.97% | View data |
| 6 | 6 Netherlands | 3.97 | 2023 | +2.4% | -4.22% | View data |
| 7 | 7 Austria | 2.06 | 2021 | View data | ||
| 8 | 8 Hungary | 1.65 | 2023 | +6.14% | +6.2% | View data |
| 9 | 9 Czechia | 1.24 | 2023 | |||
| 10 | 10 Spain | 1.19 | 2023 | +29.83% | +21.17% | View data |
